| 000 | 01670cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030756.0 | ||
| 008 | 130224s2012 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.18.M.Sc.2012.Al.L | ||
| 100 | 0 | _aAlmetwaly Mohammed Sultan | |
| 245 | 1 | 0 |
_aLong term outcome of patients with hairy cell leukemia : _bSingle center experience / _cAlmetwaly Mohammed Sultan ; Supervised Nehad Mohamed Tawfek , Mohamed Abdelmoati Mohamed |
| 246 | 1 | 5 | _aالمتابعة طويلة الأجل لمرضى لوكميا الخلايا المشعرة بعد تلقى جرعة واحدة من عقار الكلادرابين بمعهد ناصر |
| 260 |
_aCairo : _bAlmetwaly Mohammed Sultan , _c2012 |
||
| 300 |
_a112P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
| 520 | _aThe aim of this study is to evaluate the Long Term Outcome of Patients with hairy cell leukemia afer single cycle of 2 - chlorodeoxyadenosine (Cladribine) . Thirty three patients with hairy cell leukemia received a single dose of cladribine at a dose of 0.09 mg / kg / day for seven days by continous I. V. route | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aChlorodeoxyadenosine | |
| 653 | 4 | _aHairy cell leukemia | |
| 653 | 4 | _aLeukemia therapy | |
| 700 | 0 |
_aMohamed Abdelmoati Mohamed , _eSupervisor |
|
| 700 | 0 |
_aNehad Mohamed Tawfek , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c41682 _d41682 |
||